Simon C. Baker
Simon C. Baker
Research Fellow, University of York
Verified email at - Homepage
Cited by
Cited by
Characterisation of electrospun polystyrene scaffolds for three-dimensional in vitro biological studies
SC Baker, N Atkin, PA Gunning, N Granville, K Wilson, D Wilson, ...
Biomaterials 27 (16), 3136-3146, 2006
The relationship between the mechanical properties and cell behaviour on PLGA and PCL scaffolds for bladder tissue engineering
SC Baker, G Rohman, J Southgate, NR Cameron
Biomaterials 30 (7), 1321-1328, 2009
Recreational ketamine: from pleasure to pain
D Wood, A Cottrell, SC Baker, J Southgate, M Harris, S Fulford, ...
BJU international 107 (12), 1881-1884, 2011
Towards control of smooth muscle cell differentiation in synthetic 3D scaffolds
SC Baker, J Southgate
Biomaterials 29 (23), 3357-3366, 2008
Ketamine-induced apoptosis in normal human urothelial cells: a direct, N-methyl-d-aspartate receptor–independent pathway characterized by mitochondrial stress
SC Baker, S Shabir, NT Georgopoulos, J Southgate
The American journal of pathology 186 (5), 1267-1277, 2016
Nerve hyperplasia: a unique feature of ketamine cystitis
SC Baker, J Stahlschmidt, J Oxley, J Hinley, I Eardley, F Marsh, D Gillatt, ...
Acta neuropathologica communications 1, 1-7, 2013
Aquaporin Expression Contributes to Human Transurothelial Permeability In Vitro and Is Modulated by NaCl
PC Rubenwolf, NT Georgopoulos, LA Kirkwood, SC Baker, J Southgate
PLOS ONE 7 (9), e45339, 2012
The Human Tissue–Biomaterial Interface: A Role for PPARγ-Dependent Glucocorticoid Receptor Activation in Regulating the CD163+ M2 Macrophage Phenotype
SJ Bullers, SC Baker, E Ingham, J Southgate
Tissue Engineering Part A 20 (17-18), 2390-2401, 2014
Heparin functionalisation of porous PLGA scaffolds for controlled, biologically relevant delivery of growth factors for soft tissue engineering
G Rohman, SC Baker, J Southgate, NR Cameron
Journal of Materials Chemistry 19 (48), 9265-9273, 2009
Biomimetic Urothelial Tissue Models for the in Vitro Evaluation of Barrier Physiology and Bladder Drug Efficacy
SC Baker, S Shabir, J Southgate
Molecular pharmaceutics 11 (7), 1964-1970, 2014
Intratumoural cytochrome P450 expression in breast cancer: impact on standard of care treatment and new efforts to develop tumour-selective therapies
S Sneha, SC Baker, A Green, S Storr, R Aiyappa, S Martin, K Pors
Biomedicines 9 (3), 290, 2021
Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer
SC Baker, AS Mason, RG Slip, KT Skinner, A Macdonald, O Masood, ...
Oncogene 41 (15), 2139-2151, 2022
Genome-wide linkage and association study implicates the 10q26 region as a major genetic contributor to primary nonsyndromic vesicoureteric reflux
JM Darlow, R Darlay, MG Dobson, A Stewart, P Charoen, J Southgate, ...
Scientific reports 7 (1), 14595, 2017
Differential transcription factor expression by human epithelial cells of buccal and urothelial derivation
A Hustler, I Eardley, J Hinley, J Pearson, F Wezel, F Radvanyi, SC Baker, ...
Experimental cell research 369 (2), 284-294, 2018
A rare urachal cyst in a case of ketamine-induced cystitis provides mechanistic insights
E Kidger, J Stahlschmidt, M Garthwaite, S Fulford, J Southgate, SC Baker
Urology 90, 223. e1-223. e7, 2016
Cellular Integration and Vascularisation Promoted by a Resorbable, Particulate‐Leached, Cross‐Linked Poly (ε‐caprolactone) Scaffold
SC Baker, G Rohman, J Hinley, J Stahlschmidt, NR Cameron, ...
Macromolecular bioscience 11 (5), 618-627, 2011
Differentiation‐associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic‐metabolizing activity of “luminal” muscle‐invasive bladder cancers
SC Baker, VM Arlt, R Indra, M Joel, M Stiborová, I Eardley, N Ahmad, ...
Molecular Carcinogenesis 57 (5), 606-618, 2018
Procarcinogen activation and mutational signatures model the initiation of carcinogenesis in human urothelial tissues in vitro
SC Baker, AS Mason, J Southgate
European Urology 78 (2), 143-147, 2020
Bladder tissue regeneration
SC Baker, J Southgate
Electrospinning for tissue regeneration, 225-241, 2011
Does a novel mutagenic process target KMT2D mutation in the most common first event on the path to bladder cancer?
SC Baker, AS Mason, J Southgate
European urology 79 (3), 435-436, 2021
The system can't perform the operation now. Try again later.
Articles 1–20